NIP
Nicholas Investment Partners Portfolio holdings
AUM
$1.12B
1-Year Return
50.66%
This Quarter Return
+10.74%
1 Year Return
+50.66%
3 Year Return
+286.38%
5 Year Return
+525.06%
10 Year Return
+2,262.45%
AUM
$1.14B
AUM Growth
+$47.3M
(+4.3%)
Cap. Flow
-$99.5M
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.14%
Holding
260
New
32
Increased
64
Reduced
41
Closed
33
Top Buys
| 1 |
Rush Street Interactive
RSI
|
$15M |
| 2 |
Shake Shack
SHAK
|
$9.89M |
| 3 |
BILL Holdings
BILL
|
$7.33M |
| 4 |
VRNA
Verona Pharma
VRNA
|
$7.19M |
| 5 |
Astera Labs
ALAB
|
$7.03M |
Top Sells
| 1 |
Transmedics
TMDX
|
$13.7M |
| 2 |
Halozyme
HALO
|
$9.49M |
| 3 |
Cavco Industries
CVCO
|
$9.03M |
| 4 |
MGIC Investment
MTG
|
$7.71M |
| 5 |
Red Rock Resorts
RRR
|
$6.73M |
Sector Composition
| 1 | Technology | 23.1% |
| 2 | Industrials | 21.35% |
| 3 | Healthcare | 13.07% |
| 4 | Financials | 11.12% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Ross Stores
ROST
$50B
| $1.06M | 0.09% |
6,988
| – | – |
|
152
Shopify
SHOP
$189B
| $1.02M | 0.09% |
9,569
| – | – |
|
153
Birkenstock
BIRK
$9.31B
| $932K | 0.08% |
16,449
+8,441
| +105% | +$478K |
|
|
154
Cavco Industries
CVCO
$4.4B
| $919K | 0.08% |
2,059
-20,239
| -91% | -$9.03M |
|
155
CAVA Group
CAVA
$7.65B
| $865K | 0.08% |
7,670
| – | – |
|
156
Axsome Therapeutics
AXSM
$6.21B
| $858K | 0.08% |
10,135
| – | – |
|
157
Arista Networks
ANET
$177B
| $852K | 0.07% |
+7,710
| New | +$852K |
|
158
Oracle
ORCL
$626B
| $850K | 0.07% |
5,100
| – | – |
|
159
Willis Towers Watson
WTW
$32.2B
| $846K | 0.07% |
2,700
| – | – |
|
160
DraftKings
DKNG
$23.5B
| $808K | 0.07% |
21,710
-2,498
| -10% | -$92.9K |
|
161
Repligen
RGEN
$6.78B
| $804K | 0.07% |
5,587
-38,195
| -87% | -$5.5M |
|
162
Harrow
HROW
$1.34B
| $799K | 0.07% |
23,822
-45,655
| -66% | -$1.53M |
|
163
Krystal Biotech
KRYS
$4.33B
| $797K | 0.07% |
5,086
-13,721
| -73% | -$2.15M |
|
164
iShares US Medical Devices ETF
IHI
$4.31B
| $795K | 0.07% |
+13,629
| New | +$795K |
|
165
Lam Research
LRCX
$127B
| $779K | 0.07% |
+10,783
| New | +$779K |
|
166
CorMedix
CRMD
$956M
| $762K | 0.07% |
+94,132
| New | +$762K |
|
167
Biohaven
BHVN
$1.7B
| $697K | 0.06% |
18,673
-6,776
| -27% | -$253K |
|
168
Praxis Precision Medicines
PRAX
$970M
| $653K | 0.06% |
+8,481
| New | +$653K |
|
169
Flowserve
FLS
$7.13B
| $623K | 0.05% |
10,833
| – | – |
|
170
Xenon Pharmaceuticals
XENE
$2.98B
| $575K | 0.05% |
14,658
| – | – |
|
|
171
Halozyme
HALO
$8.59B
| $545K | 0.05% |
11,395
-198,524
| -95% | -$9.49M |
|
172
Marvell Technology
MRVL
$55.3B
| $542K | 0.05% |
+4,906
| New | +$542K |
|
173
Mercado Libre
MELI
$123B
| $524K | 0.05% |
308
| – | – |
|
174
Cytokinetics
CYTK
$5.95B
| $520K | 0.05% |
11,049
| – | – |
|
175
Domino's
DPZ
$15.7B
| $507K | 0.04% |
1,209
+362
| +43% | +$152K |
|